β-Catenin and its relation to VEGF and cyclin D1 expression in pT3 rectosigmoid cancers

Turkish Journal of Gastroenterology

Volumn 21, Issue 4, 2010, Pages 365-371

  Dilek, Fatma Hüsniye ^a   Topak, Nevin ^a   Tokyol, Çiǧdem ^a   Akbulut, Gökhan ^a   Dilek, Osman Nuri ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

catenin; Colorectal carcinoma; Cyclin D1; Vascular endothelial growth factor; Wnt signaling

Indexed keywords

BETA CATENIN; CYCLIN D1; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; COLON ADENOCARCINOMA; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER METASTASIS; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; COLORECTAL NEOPLASMS; CYCLIN D1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; SIGMOID NEOPLASMS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WNT PROTEINS;

EID: 79951971006     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2010.0122     Document Type: Article

References (39)

1. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4.
2. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-76. (Pubitemid 36749215)
3. Takahashi Y, Tucker SL, Kitadai Y, et al. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 1997; 132: 541-6. (Pubitemid 27215097)
4. Lin SY, Xia W, Wang JC, et al. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci U S A 2000; 97: 4262-6.
5. Bondi J, Bukholm G, Nesland JM, Bukholm IRK. Expression of non-membranous β-catenin and γ-catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas. APMIS 2004; 112: 49-56.
6. Gavert N, Ben-Ze'ev A. beta-Catenin signaling in biological control and cancer. J Cell Biochem 2007; 102: 820-8. (Pubitemid 350036922)
7. Doucas H, Garcea G, Neal CP, et al. Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer 2005; 41: 365-79. (Pubitemid 40187207)
8. Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (Lond) 1999; 398: 422-6. (Pubitemid 29180374)
9. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-12. (Pubitemid 28425575)
10. Easwaran V, Lee SH, Inge L, et al. Beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 2003; 63: 3145-53. (Pubitemid 36735866)
11. th ed. New York: Springer Verlag, 2002; 127-9.
12. Hamilton SR, Aaltonen LA, eds. WHO classification of tumors. Pathology and genetics. Tumors of digestive system organs. Lyon: IARC Press, 2000.
13. Saegusa M, Hashimura M, Hara A, Okayasu I. Up-regulation of pS2 expression during the development of adenocarcinomas but not squamous cell carcinomas of the uterine cervix, independently of expression of c-jun or oestrogen and progesterone receptors. J Pathol 2000; 190: 554-63. (Pubitemid 30164485)
14. Wong SC, Lo ES, Lee KC, et al. Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer. Clin Cancer Res 2004; 10: 1401-8. (Pubitemid 38365235)
15. Lugli A, Zlobec I, Minoo P, et al. Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarraybased analysis. Histopathology 2007; 50: 453-64. (Pubitemid 46328181)
16. Maruyama K, Ochiai A, Akimoto S, et al. Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology 2000; 59: 302-9.
17. Chung GG, Provost E, Kielhorn EP, et al. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis. Clin Cancer Res 2001; 7: 4013-20. (Pubitemid 34044621)
18. Gunther K, Brabletz T, Kraus C, et al. Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer. Dis Colon Rectum 1998; 41: 1256-61. (Pubitemid 28477975)
19. Des Guetz G, Uzzan B, Nicolas P, et al. Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer 2006; 94: 1823-32. (Pubitemid 43882572)
20. Khorana AA, Ryan CK, Cox C, et al. Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis. Cancer 2003; 97: 960-8.
21. Zafirellis K, Agrogiannis G, Zachaki A, et al. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer. J Surg Res 2008; 147: 99-107. (Pubitemid 351626074)
22. Ochs AM, Wong L, Kakani V, et al. Expression of vascular endothelial growth factor and HER2/neu in stage II colon cancer and correlation with survival. Clin Colorectal Cancer 2004; 4: 262-7. (Pubitemid 40012323)
23. Saad RS, Liu YL, Nathan G, et al. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol 2004; 17: 197-203. (Pubitemid 41656516)
24. Zheng S, Han MY, Xiao ZX, et al. Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma. World J Gastroenterol 2003; 9: 1227-30. (Pubitemid 36805657)
25. Zhang X, Gaspard JP, Chung DC. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 2001; 61: 6050-4. (Pubitemid 32762538)
26. McKay JA, Douglas JJ, Ross VG, et al. Analysis of key cellcycle checkpoint proteins in colorectal tumours. J Pathol 2002; 196: 386-93.
27. Arber N, Hibshoosh H, Moss SF, et al. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 1996; 110: 669-74. (Pubitemid 26071834)
28. Bondi J, Husdal A, Bukholm G, et al. Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome. J Clin Pathol 2005; 58: 509-14.
29. Maeda K, Chung Y, Kang S, et al. Cyclin D1 overexpression and prognosis in colorectal adenocarcinoma. Oncology 1998; 55: 145-51. (Pubitemid 28052259)
30. Kouraklis G, Theocharis S, Vamvakas P, et al. Cyclin D1 and Rb protein expression and their correlation with prognosis in patients with colon cancer. World J Surg Oncol 2006; 4: 5.
31. Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 1999; 96: 5522-7. (Pubitemid 29234650)
32. Utsunomiya T, Doki Y, Takemoto H, et al. Correlation of beta-catenin and cyclin D1 expression in colon cancers. Oncology 2001; 61: 226-33. (Pubitemid 34701538)
33. Wang HL, Wang J, Xiao SY, et al. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Int J Cancer 2002; 101: 301-10. (Pubitemid 34983184)
34. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275: 1787-90. (Pubitemid 27136715)
35. Mann B, Gelos M, Siedow A, et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A 1999; 96: 1603-8. (Pubitemid 29098498)
36. Klymkowsky MW. Beta-catenin and its regulatory network. Hum Pathol 2005; 36: 225-7.
37. Zhang C, Basta T, Jensen ED, Klymkowsky MW. The beta-catenin/VegT- regulated early zygotic gene Xnr5 is a direct target of SOX3 regulation. Development 2003; 130: 5609-24. (Pubitemid 37540838)
38. Neufeld KL, Nix DA, Bogerd H, et al. Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc Natl Acad Sci U S A 2000; 97: 12085-90.
39. Henderson BR, Galea M, Schuechner S, Leung L. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1. J Biol Chem 2002; 277: 24258-64. (Pubitemid 34951943)